Laurus Labs Limited vs RPG Life Sciences Limited

A side-by-side comparison of Laurus Labs Limited (LAURUSLABS) and RPG Life Sciences Limited (RPGLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, RPG Life Sciences Limited leads LAURUSLABS vs RPGLIFE on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation04
  • Profitability13
  • Growth02
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

RPGLIFE takes 4/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

125.08
P/E ratio
41.98
19.74
P/B ratio
8.01
0.10%
Dividend yield
0.82%
₹16.47
EPS
₹69.64

Profitability

RPGLIFE takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

16.77%
Return on equity
19.02%
17.58%
Return on capital
24.80%
26.09%
EBITDA margin
20.79%
13.07%
Net margin
16.28%

Growth

RPGLIFE takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

4.09%
Revenue CAGR (3Y)
11.31%
3.91%
Profit CAGR (3Y)
19.20%

Size & financial health

LAURUSLABS takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.11L Cr
Market cap
₹4,865 Cr
₹6,813 Cr
Revenue
₹708 Cr
₹890 Cr
Net profit
₹115 Cr
0.45
Debt / equity
0.03
Laurus Labs Limited
  • + []
  • − ["Stock is trading at 21.00 times its book value", "The company has delivered a poor sales growth of 7.2% over past five years.", "The company has delivered a poor profit growth of -2.0% over past five years."]
RPG Life Sciences Limited
  • + ["Company has delivered good profit growth of 23.6% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 28.8%", "Company has been maintaining a healthy dividend payout of 34.5%", "Company is almost debt free."]
  • − ["Stock is trading at 8.03 times its book value"]
Laurus Labs Limited full analysis RPG Life Sciences Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.